List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 73 studies with search of: Open Studies | "Conjunctivitis"
Include studies that are not seeking new volunteers.
Hide studies with unknown recruitment status.
  Display Options
Rank Status Study
1 Not yet recruiting FST-100 in the Treatment of Acute Adenoviral Conjunctivitis
Condition: Acute Adenoviral Conjunctivitis
Interventions: Drug: FST-100;   Drug: FST-100 (Component #1);   Drug: FST-100 Vehicle
2 Recruiting The Effect of BEPREVE 1.5% as Treatment of Itching Associated With Allergic Conjunctivitis
Condition: Allergic Conjunctivitis
Intervention: Drug: Bepreve® 1.5% solution
3 Recruiting A Trial of Topical Dexamethasone Versus Artificial Tears for Treatment of Viral Conjunctivitis
Condition: Viral Conjunctivitis
Interventions: Drug: dexamethasone 0.1%/povidone-iodine 0.4%;   Drug: Artificial Tears
4 Not yet recruiting Bepreve vs. Alrex in Subjects With Moderate to Severe Allergic Conjunctivitis
Condition: Allergic Conjunctivitis
Interventions: Drug: bepotastine besilate, 1.5%;   Drug: Loteprednol etabonate
5 Not yet recruiting Efficacy Maxinom® And Maxitrol® in Reducing The Signs And Symptoms Of Acute Bacterial Conjunctivitis
Conditions: Bacterial Conjunctivitis;   Acute
Interventions: Drug: MAXINOM®;   Drug: Maxitrol®
6 Not yet recruiting Effectiveness Comparison Between the Drugs TOBRACORT® and TOBRADEX® in Reducing the Signs and Symptoms of Acute Bacterial Conjunctivitis
Condition: Acute Bacterial Conjunctivitis
Interventions: Drug: Tobracort;   Drug: Tobradex
7 Recruiting A Study to Evaluate the Safety and Efficacy of Lotemax Ophthalmic Suspension 0.5%
Conditions: Conjunctivitis, Seasonal Allergic;   Conjunctivitis, Giant Papillary;   Inflammation
Intervention: Drug: Loteprednol Etabonate
8 Not yet recruiting FST-100 in the Treatment of Acute Viral Conjunctivitis
Condition: Acute Viral Conjunctivitis
Interventions: Drug: FST-100;   Drug: FST-100 Vehicle
9 Recruiting Study of DE-114 Ophthalmic Solution in Patients With Allergic Conjunctivitis
Condition: Allergic Conjunctivitis
Interventions: Drug: DE-114 ophthalmic solution;   Drug: Placebo ophthalmic solution;   Drug: Olopatadine Hydrochloride 0.1% Ophthalmic Solution
10 Recruiting A Long-term Study of DE-114 Ophthalmic Solution in Patients With Allergic Conjunctivitis
Condition: Allergic Conjunctivitis
Intervention: Drug: DE-114 ophthalmic solution
11 Recruiting Besifloxacin Ophthalmic Suspension Verses Gatifloxacin Ophthalmic Solution in Neonates With Bacterial Conjunctivitis
Condition: Bacterial Conjunctivitis
Interventions: Drug: Besivance;   Drug: Gatifloxacin
12 Recruiting Moxifloxacin vs. Polytrim for Conjunctivitis
Condition: Conjunctivitis
Interventions: Drug: moxifloxacin;   Drug: polytrim
13 Recruiting Efficacy and Safety of AL-4943A Ophthalmic Solution in Patients With Allergic Conjunctivitis Using the Conjunctival Allergen Challenge (CAC) Model
Condition: Allergic Conjunctivitis
Interventions: Drug: AL-4943A Ophthalmic Solution;   Drug: AL-4943A Ophthalmic Solution Vehicle;   Drug: Pataday
14 Recruiting Comparison of the Efficacy and Tolerability of T1210 and Olopatadine Hydrochloride 0.1% in the Treatment of Seasonal Allergic Conjunctivitis
Condition: Seasonal Allergic Conjunctivitis
Interventions: Drug: T1210;   Drug: Olopatadine hydrochloride
15 Recruiting A Study to Evaluate the Duration of LASTACAFT™ in Acute Allergic Conjunctivitis
Condition: Conjunctivitis, Allergic
Interventions: Drug: alcaftadine 0.25% ophthalmic solution (LASTACAFT™);   Drug: olopatadine 0.2% Ophthalmic Solution (Pataday™);   Drug: hydroxypropyl methylcellulose 0.3% Ophthalmic Solution (Placebo)
16 Recruiting A Patient Reported Ocular Comfort Assessment Comparing Bepreve to Lastacaft
Condition: Allergic Conjunctivitis
Intervention:
17 Not yet recruiting A Multicenter Study to Evaluate Safety and Efficacy of Specific Immunotherapy With Modified Allergen Extracts
Conditions: Allergic Rhinitis;   Allergic Conjunctivitis
Interventions: Biological: modified allergen extract;   Biological: Placebo
18 Recruiting A Study of SCH 697243 in Participants With Grass Pollen Allergy Symptoms, With or Without Asthma (P08067 AM1)
Conditions: Rhinitis Allergic;   Conjunctivitis
Interventions: Biological: Grass (Phleum pratense) pollen allergen extract;   Biological: Placebo for SCH 697243
19 Recruiting Comparison of Different Up-dosing Schedules With Osiris Phleum Pratense
Condition: Rhino-conjunctivitis
Intervention: Biological: Osiris Phleum pratense
20 Unknown † Allergic Eye Disease Tear Mediators
Condition: Allergic Eye Disease
Intervention: Drug: olopatadine

Previous Page Studies Shown (1-20) Next Page (21-40)
† Indicates status has not been verified in more than two years
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services